IL17A and rheumatoid arthritis: Similarly, miR-146, which is found at elevated levels in RA-SFs and in response to key pathogenic mediators (e.g., IL-1β, IL-6, IL-17 and TNF-α), upregulates IRAK1 and Traf6 to enhance inflammatory signalling [25,26].